ArriVent BioPharmaAVBP
那斯達克 · USD
27.57
+0.84
(+3.14%)
盤中 05/26 11:01 (UTC+8)
05/26 11:01 (UTC+8)
ArriVent BioPharmaAVBP
27.57
+0.84
(+3.14%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 46,111 | 38,823 | 38,316 | 33,623 | 66,772 | - | - | - | - | 23,118 |
研發費用 | 37,617 | 32,175 | 32,167 | 27,720 | 61,289 | 20,163 | 20,088 | 21,778 | 16,975 | 20,010 |
推銷及管理費用 | 8,494 | 6,648 | 6,149 | 5,903 | 5,483 | 3,542 | 4,144 | 3,919 | 3,699 | 3,108 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -46,111 | -38,823 | -38,316 | -33,623 | -66,772 | -23,705 | -24,232 | -25,697 | -20,674 | -23,118 |
其他收入及費用 | 2,791 | 3,279 | 3,338 | 2,224 | 2,385 | 3,072 | 3,668 | 3,823 | 3,257 | 1,925 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -43,320 | -35,544 | -34,978 | -31,399 | -64,387 | -20,633 | -20,564 | -21,874 | -17,417 | -21,193 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -43,320 | -35,544 | -34,978 | -31,399 | -64,387 | -20,633 | -20,564 | -21,874 | -17,417 | -21,193 |
基本每股稅後盈餘(元) | -0.96 | -0.69 | -0.83 | -0.90 | -1.90 | -0.60 | -0.61 | -0.65 | -0.70 | - |
稀釋每股稅後盈餘(元) | -0.96 | -0.78 | -0.76 | -0.88 | -1.90 | -0.61 | -0.61 | -0.64 | -0.70 | -7.69 |
基本平均股數(千股) | 45067.00 | 43034.00 | 41912.00 | 35006.00 | 33898.00 | 33748.00 | 33581.00 | 33502.00 | 25046.00 | - |
稀釋平均股數(千股) | 45067.00 | 43034.00 | 41912.00 | 35006.00 | 33898.00 | 33748.00 | 33581.00 | 33502.00 | 25046.00 | - |
還原基本每股稅後盈餘(元) | -0.96 | -0.69 | -0.83 | -0.90 | -1.90 | -0.60 | -0.61 | -0.65 | -0.70 | - |
還原稀釋每股稅後盈餘(元) | -0.96 | -0.78 | -0.76 | -0.88 | -1.90 | -0.61 | -0.61 | -0.64 | -0.70 | -7.69 |
還原基本平均股數(千股) | 45,067 | 43,034 | 41,912 | 35,006 | 33,898 | 33,748 | 33,581 | 33,502 | 25,046 | - |
還原稀釋平均股數(千股) | 45,067 | 43,034 | 41,912 | 35,006 | 33,898 | 33,748 | 33,581 | 33,502 | 25,046 | - |
EBITDA(千元) | -43,879 | -38,570 | -34,978 | -31,399 | -64,387 | -20,633 | -20,564 | -21,874 | -17,417 | -21,193 |